Tsuji-Takayama K - Search Results

1

Treatment rationale and protocol design: an investigator-initiated phase II study of combination treatment of nivolumab and TM5614, a PAI-1 inhibitor for previously treated patients with non-small cell lung cancer.

Masuda T, Hirata T, Sakamoto T, Tsubata Y, Ichihara E, Kozuki T, Shoda H, Motonaga M, Yoshida T, Fukutani M, Tsuji-Takayama K, Tamura A, Amagase H, Fujihara H, Aoki G, Akita T, Orihashi Y, Miyata T, Hattori N. Masuda T, et al. Among authors: tsuji takayama k. J Thorac Dis. 2024 May 31;16(5):3381-3388. doi: 10.21037/jtd-23-1858. Epub 2024 May 27. J Thorac Dis. 2024. PMID: 38883673 Free PMC article.

2

Targeting Podoplanin for the Treatment of Osteosarcoma.

Takemoto A, Takagi S, Ukaji T, Gyobu N, Kakino M, Takami M, Kobayashi A, Lebel M, Kawaguchi T, Sugawara M, Tsuji-Takayama K, Ichihara K, Funauchi Y, Ae K, Matsumoto S, Sugiura Y, Takeuchi K, Noda T, Katayama R, Fujita N. Takemoto A, et al. Among authors: tsuji takayama k. Clin Cancer Res. 2022 Jun 13;28(12):2633-2645. doi: 10.1158/1078-0432.CCR-21-4509. Clin Cancer Res. 2022. PMID: 35381070 Free PMC article.

3

Relevance of nuclear receptor expression in a Tchreg cell line, HOZOT: RXRα and PPARγ negatively regulate IFN-γ production.

Suzuki M, Takeuchi M, Tsuji-Takayama K, Harashima A, Otani T, Toraya T, Kakuta H, Yamasaki F, Nakamura S, Kibata M. Suzuki M, et al. Among authors: tsuji takayama k. Results Immunol. 2012 Aug 19;2:158-65. doi: 10.1016/j.rinim.2012.08.001. eCollection 2012. Results Immunol. 2012. PMID: 24371580 Free PMC article.

4

Potent anti-tumor killing activity of the multifunctional Treg cell line HOZOT against human tumors with diverse origins.

Inoue T, Tashiro Y, Takeuchi M, Otani T, Tsuji-Takayama K, Okochi A, Mukae Y, Koreishi M, Yamasaki F, Kumon H, Nakamura S, Kibata M, Kondo E. Inoue T, et al. Among authors: tsuji takayama k. Int J Oncol. 2011 May;38(5):1299-306. doi: 10.3892/ijo.2011.962. Epub 2011 Mar 3. Int J Oncol. 2011. PMID: 21373756

5

miR-155, a Modulator of FOXO3a Protein Expression, Is Underexpressed and Cannot Be Upregulated by Stimulation of HOZOT, a Line of Multifunctional Treg.

Yamamoto M, Kondo E, Takeuchi M, Harashima A, Otani T, Tsuji-Takayama K, Yamasaki F, Kumon H, Kibata M, Nakamura S. Yamamoto M, et al. Among authors: tsuji takayama k. PLoS One. 2011 Feb 3;6(2):e16841. doi: 10.1371/journal.pone.0016841. PLoS One. 2011. PMID: 21304824 Free PMC article.

6

Stromal cells' B7-1 is a key stimulatory molecule for interleukin-10 production by HOZOT, a multifunctional regulatory T-cell line.

Otani T, Tsuji-Takayama K, Okochi A, Yamamoto M, Takeuchi M, Yamasaki F, Nakamura S, Kibata M. Otani T, et al. Among authors: tsuji takayama k. Immunol Cell Biol. 2011 Feb;89(2):246-54. doi: 10.1038/icb.2010.87. Epub 2010 Jul 13. Immunol Cell Biol. 2011. PMID: 20628373

7

Interleukin-8 and RANTES are signature cytokines made by HOZOT, a new type of regulatory T cells.

Harashima A, Toraya T, Okochi A, Yamamoto M, Suzuki M, Otani T, Inoue T, Tsuji-Takayama K, Sugimoto A, Takeuchi M, Yamasaki F, Nakamura S, Kibata M. Harashima A, et al. Among authors: tsuji takayama k. Mol Immunol. 2009 Oct;46(16):3310-9. doi: 10.1016/j.molimm.2009.07.023. Epub 2009 Aug 21. Mol Immunol. 2009. PMID: 19699525

8

The production of IL-10 by human regulatory T cells is enhanced by IL-2 through a STAT5-responsive intronic enhancer in the IL-10 locus.

Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Toraya T, Takeuchi M, Yamasaki F, Nakamura S, Kibata M. Tsuji-Takayama K, et al. J Immunol. 2008 Sep 15;181(6):3897-905. doi: 10.4049/jimmunol.181.6.3897. J Immunol. 2008. PMID: 18768844

9

IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.

Tsuji-Takayama K, Suzuki M, Yamamoto M, Harashima A, Okochi A, Otani T, Inoue T, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M. Tsuji-Takayama K, et al. Exp Hematol. 2008 Feb;36(2):181-92. doi: 10.1016/j.exphem.2007.09.010. Epub 2007 Nov 26. Exp Hematol. 2008. PMID: 18023521 Free article.

10

Comprehensive analysis of FOXP3 mRNA expression in leukemia and transformed cell lines.

Yamamoto M, Tsuji-Takayama K, Suzuki M, Harashima A, Sugimoto A, Motoda R, Yamasaki F, Nakamura S, Kibata M. Yamamoto M, et al. Among authors: tsuji takayama k. Leuk Res. 2008 Apr;32(4):651-8. doi: 10.1016/j.leukres.2007.08.020. Epub 2007 Oct 24. Leuk Res. 2008. PMID: 17920118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters